Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MEK Inhibitors for the Treatment of Hypertrophic Cardiomyopathy in Patients With RASopathies (MEKinRAS) - Randomized Controlled Trial

NCT06555237 is registered in ClinicalTrials.gov with Medical University of Warsaw as lead sponsor.

NCT NCT06555237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06555237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MEK Inhibitors for the Treatment of Hypertrophic Cardiomyopathy in Patients With RASopathies (MEKinRAS) - Randomized Controlled Trial
Lead sponsor
Medical University of Warsaw
Phase
Phase 2
Overall status
Recruiting
Start date
August 1, 2024
Completion date
December 1, 2026
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiomegaly, noonan syndrome